July 12, 2013—The Senate Republican who has been examining hospitals’ participation in the 340B program and the trade association for brand-name drug manufacturers have responded to a major new report on the 340B drug discount program.
You must be registered to read complete articles (it's quick, easy, and 100% free). Click here to register. Already registered? Click here to login. (340B Health members, Drug Discount Monitor subscribers, and 340B Coalition conference attendees: Use your existing username and password.)